ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[PRL, HGS]
GO:0007253;cytoplasmic sequestering of NF-kappaB;13.0;1.0;0.9625549647676366;9.628524252492122;578.6196231821564;7.8311634786251565;0.019365878064054164;0.8630410292508717;[CCDC22]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[TGFB1, CLDN4]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TGFB1]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[TGFB1]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[TGFB1, POLA2, AKT1, RAN]
GO:0030948;negative regulation of vascular endothelial growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;297.5747140953686;7.474488534686424;0.00995955788091634;0.7331650565203278;[HGS]
GO:0050435;amyloid-beta metabolic process;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;60.01596331221528;6.943860283624253;0.0020086802811995464;0.6782296504172152;[APEH]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[CDH3, AKT1, MMP12, TGFB1]
GO:0070723;response to cholesterol;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;80.91680144162417;6.686031174322154;0.002708212523857764;0.665044257777226;[OSBPL7, TGFB1]
GO:0048009;insulin-like growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.138016298065211;0.0010376185600805164;0.7400384854347593;[AKT1, TSC2]
GO:0008354;germ cell migration;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;40.540081573954176;7.57984905034425;0.0013568400465755524;0.6778748447945537;[TGFB1]
GO:0006611;protein export from nucleus;9.0;0.7508913569872202;0.7716863036738992;9.277126365654233;128.4390295807893;5.948432231191374;0.00429873873244698;0.7004437261138039;[, XPO1, NUP62, NUP88, TGFB1, NUPL2, RAN]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[TSC2]
GO:0043117;positive regulation of vascular permeability;6.0;1.0;0.8231203125901445;9.628524252492122;22.58320658440663;7.474488534686424;7.558396008136816E-4;0.7053660038532718;[TGFB1]
GO:0045662;negative regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;6.518977089658987;0.0038363580074348307;0.6565011041187423;[TGFB1]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP107, NUP62, NUP133, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP1, NUP155, NUP35, RAN]
GO:0050680;negative regulation of epithelial cell proliferation;6.0;0.7307253602413294;0.6884829927108091;8.690254613899192;65.19530579150691;4.989581884898423;0.0021820282128758306;0.5782877622231366;[PRL, SFN, TGFB1]
GO:0001837;epithelial to mesenchymal transition;5.0;0.7508913569872202;0.6656866903545304;8.647694999480395;23.145667324477426;5.618190544320798;7.746646556020492E-4;0.5775555375700647;[TGFB1]
GO:0030497;fatty acid elongation;9.0;0.8436909121759173;0.8180860812682478;9.50592193039979;362.333458048015;7.292166977892469;0.012126974761925657;0.769162383550154;[TECR]
GO:2000249;regulation of actin cytoskeleton reorganization;8.0;0.8933024483968273;0.8216512241984136;9.427853557029971;36.19570401534177;6.221725566191056;0.0012114376393747596;0.6931793347948383;[TGFB1]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[FGF5, TGFB1]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[TSC2, AKT1]
GO:1903543;positive regulation of exosomal secretion;9.0;1.0;0.896240625180289;9.628524252492122;273.97956964224545;7.069023426578259;0.009169849630321672;0.757750811958709;[HGS]
GO:0097191;extrinsic apoptotic signaling pathway;6.0;0.8259837884571596;0.7361122068187242;9.223059144383958;51.05903939735586;5.277263957350204;0.0017089000984773794;0.5929998367869052;[TGFB1]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[AKT1, CCDC22, NUP62, FLNA]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[FBXO5, SFN, CDC6, EZH2, PCNA, SIPA1, GMNN, KNTC1, TGFB1, CNOT3, SMC1A, E2F7, WEE1, RAD51]
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;6.063501560976162;0.008015432820232688;0.6850877518099798;[CCDC22]
GO:0060389;pathway-restricted SMAD protein phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.212124270218933;0.006049650283656873;0.7438283705770736;[TGFB1]
GO:0033081;regulation of T cell differentiation in thymus;9.0;0.7866048967936545;0.7895430735771163;9.417215158824915;133.46855707074621;6.558197802812269;0.004467072491254967;0.7316271658034954;[CLPTM1]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[TLN1, STXBP2, FLNA, TGFB1]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[FGF5, TGFB1, SPTAN1, MAP4K1]
GO:0043491;protein kinase B signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.250713103064308;8.845336528452411E-4;0.6427820713687392;[TGFB1, TSC2, AKT1]
GO:0031339;negative regulation of vesicle fusion;7.0;0.8436909121759173;0.7727648213451592;9.392135474427892;149.70009243093662;7.9853141584524145;0.00501032737232711;0.7592887026755414;[CORO1A]
GO:0051781;positive regulation of cell division;5.0;0.6763753087927167;0.6284286662572787;8.438940185618286;42.28939918509474;5.358233019883872;0.0014153881327367882;0.5642612976810992;[FGF5, NUP62, TGFB1, CDC6, CIT]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, IFNA14, IFNA16, IFNA10, IFNA21, IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TGFB1]
GO:0043011;myeloid dendritic cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;91.1712242271392;6.8867018697843045;0.003051418826107602;0.6753065664753021;[TGFB1]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[TGFB1, CDC6]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[CORO1A, ATP2A3]
GO:0016197;endosomal transport;5.0;0.7090535922965819;0.6447678080092112;8.817594036275793;47.18803257139101;4.463867648638682;0.0015793409836922997;0.5185234110033771;[HGS]
GO:0071158;positive regulation of cell cycle arrest;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;83.12201169572153;5.395046993006588;0.002782018926502022;0.6268223193749;[PCNA, SFN, E2F7, TGFB1, CNOT3]
GO:0060391;positive regulation of SMAD protein signal transduction;8.0;1.0;0.875;9.628524252492122;234.98809543662418;7.292166977892469;0.007864840078708074;0.747921758369865;[TGFB1]
GO:0031334;positive regulation of protein complex assembly;6.0;0.612588685250814;0.6294146552155515;8.094593892566166;105.21570715161425;4.251620688548686;0.0035214750303757575;0.5405483923231058;[TGFB1, BIK, NR1H2, GTF2H1]
GO:1903799;negative regulation of production of miRNAs involved in gene silencing by miRNA;10.0;0.8933024483968273;0.861892236059334;9.5758805190067;949.8698671053862;7.697632086000634;0.031791289624636974;0.8088982747154926;[TGFB1]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[AKT1, TGFB1]
GO:1990314;cellular response to insulin-like growth factor stimulus;8.0;1.0;0.875;9.628524252492122;388.66587636398185;7.57984905034425;0.013008297105323164;0.7626338329336335;[TGFB1]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[PPP2R1A, AKT1, SFN, TSC2, TGFB1, NUP62]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[CORO1A, NUP85, TGFB1, EPCAM]
GO:0030595;leukocyte chemotaxis;6.0;0.6873818243518346;0.6668112247660618;8.768322987269011;62.06300720445581;4.857092701852345;0.002077192998052941;0.5715122592407831;[CORO1A, NUP85]
GO:0010763;positive regulation of fibroblast migration;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;201.49065414776382;7.379178354882098;0.006743710864509851;0.7523715242355574;[TGFB1, AKT1]
GO:0010642;negative regulation of platelet-derived growth factor receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;188.1075192762445;7.212124270218933;0.006295789384399518;0.7197477358342742;[HGS]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[TGFB1]
GO:0021915;neural tube development;5.0;1.0;0.7902410118609202;9.628524252492122;33.009488292418915;6.409777797693995;0.0011047978665365144;0.618037346520142;[TGFB1, NUP133]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[AKT1, TGFB1]
GO:1901666;positive regulation of NAD+ ADP-ribosyltransferase activity;6.0;1.0;0.8231203125901445;9.628524252492122;49.122279745261444;8.67846133901236;0.0016440784958923031;0.7669372290569613;[TGFB1]
GO:0045840;positive regulation of mitotic nuclear division;8.0;0.7140352122741334;0.7320176061370667;9.138976027173417;276.06341799230654;5.75172193694532;0.009239594159256459;0.6691433273378073;[NUP62, SH2B1, RANBP1, TGFB1]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[EZH2, ARHGAP6, RHOG, RANBP1, SIPA1, TSC2, ACAP1]
GO:0043304;regulation of mast cell degranulation;10.0;0.7980440201809971;0.8142630219514189;9.523163736834295;224.79395709788088;6.409777797693995;0.007523651442639206;0.7430373465201421;[STXBP2]
GO:0032801;receptor catabolic process;6.0;0.8436909121759173;0.7449657686781032;9.34084218004034;102.12013474586499;6.518977089658987;0.003417869007789623;0.6565011041187423;[TGFB1, AP2M1]
GO:0006878;cellular copper ion homeostasis;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;186.04478652569694;7.138016298065211;0.006226751575577643;0.7802794972956796;[CCDC22]
GO:0030509;BMP signaling pathway;11.0;0.7090535922965819;0.7869557484779532;9.133828010656014;282.55034729266697;5.202362649177086;0.009456705845082177;0.6984780201431826;[TGFB1]
GO:2000278;regulation of DNA biosynthetic process;7.0;0.6913464685778243;0.6965925995461126;9.040737587590003;150.73814970462044;5.152100814396198;0.005045070215086414;0.6143980405026119;[SH2B1]
GO:0019049;evasion or tolerance of host defenses by virus;9.0;0.660418147677249;0.7264496990189135;8.890925309361343;177.3716437189982;8.390779266560578;0.005936469291159198;0.8253454670833372;[TGFB1]
GO:0032007;negative regulation of TOR signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;5.926926025970411;0.008015432820232688;0.6781032725983739;[TSC2]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[TGFB1]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[TGFB1]
GO:0007182;common-partner SMAD protein phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.9853141584524145;0.006049650283656873;0.7833693374183408;[TGFB1]
GO:0007183;SMAD protein complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;44.51706700895919;7.8311634786251565;0.0014899461700306506;0.7236063770733796;[TGFB1]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[TGFB1]
GO:0006893;Golgi to plasma membrane transport;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;32.11060110714162;5.845247994956144;0.0010747129213912287;0.6498456195510879;[CCDC22]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[JUP, APEH, STXBP2, NBEAL2, SPTAN1, RHOG]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CORO1A]
GO:0060312;regulation of blood vessel remodeling;5.0;0.8259837884571596;0.7032329060895001;9.377209824211215;28.902788426864877;7.57984905034425;9.673503178263487E-4;0.6778748447945537;[TGFB1]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[AP2M1, TSC2, CORO1A]
GO:2000727;positive regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;667.9527156383532;6.8867018697843045;0.02235577627399952;0.7484268790654467;[TGFB1]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[TGFB1]
GO:0051056;regulation of small GTPase mediated signal transduction;7.0;0.6799073451904818;0.6908730378524415;8.647694999480395;45.070113835906206;4.018171853803189;0.001508456149618737;0.5564088607247961;[STMN1, TSC2, ARHGAP6, NUP62, RHOG, EPS8L1, SIPA1]
GO:0045066;regulatory T cell differentiation;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;66.99450330244977;8.390779266560578;0.002242245734394454;0.7800242071602487;[TGFB1]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[PCNA, TGFB1, EZH2]
GO:0072657;protein localization to membrane;5.0;0.5756379274792419;0.5780599756005412;7.585450354983161;29.829169826127035;3.7017275965917853;9.983554695705216E-4;0.4795475332985618;[JUP, FLNA, CDH1, HGS, NUP155, NUP54]
GO:0030178;negative regulation of Wnt signaling pathway;7.0;0.6835726970475526;0.6927057137809769;8.781226392104918;188.91844949246428;4.7018998124466425;0.006322930488946581;0.591374740326424;[TLE4, TSC2, AES]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[FGF5, IFNA14, IFNA16, IFNA10, IFNA21, TGFB1, IFNA5, IFNA4, IFNA7, IFNA2, PRL, IFNA8]
GO:0050765;negative regulation of phagocytosis;8.0;0.8436909121759173;0.7968454560879586;9.503361109538115;175.4194889364855;7.069023426578259;0.005871132427413739;0.7365101867784198;[TGFB1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, SKP2, PCNA, UBE2M, HIST1H2BK]
GO:0035066;positive regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1302.9179711131005;6.444869117505266;0.043607491943109866;0.7620198587159455;[TGFB1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CORO1A, RHOG]
GO:0014003;oligodendrocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;6.558197802812269;0.001141266750656509;0.6256275524841266;[TGFB1]
GO:2000060;positive regulation of ubiquitin-dependent protein catabolic process;10.0;0.811012628672052;0.8207473261969463;9.483342242647623;1661.590298646008;5.192106149009898;0.055611931961498426;0.6807655617789147;[AKT1, CCDC22]
GO:0043320;natural killer cell degranulation;9.0;1.0;0.896240625180289;9.628524252492122;133.05394577034187;8.16763571524637;0.004453195824156379;0.8139338954918922;[CORO1A]
GO:1902895;positive regulation of pri-miRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1721.2385553242598;6.599019797332524;0.0576083054325737;0.7855944919115336;[TGFB1, PRL]
GO:1901203;positive regulation of extracellular matrix assembly;7.0;1.0;0.8509193652572005;9.628524252492122;123.61133381433942;8.16763571524637;0.004137160099788013;0.7686126355688037;[TGFB1]
GO:0006622;protein targeting to lysosome;11.0;0.9326813400603323;0.8987696223598284;9.592156608321247;250.3799473132135;6.781341354126479;0.008379991509250163;0.7792270645443136;[HGS]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[SKP2, CCDC22, UBE2M]
GO:0042482;positive regulation of odontogenesis;7.0;0.8436909121759173;0.7727648213451592;9.474373572664863;103.86878039186215;7.379178354882098;0.0034763946038822383;0.728290889492758;[TGFB1]
GO:0001845;phagolysosome assembly;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;81.92137458931388;8.16763571524637;0.002741834683053802;0.7686126355688037;[CORO1A]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[CORO1A, MCM2]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[TGFB1, RAD51]
GO:1903077;negative regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.4949928598676;218.53196919702376;6.686031174322154;0.007314068343020746;0.7169239451870815;[TGFB1, AP2M1]
GO:0007162;negative regulation of cell adhesion;5.0;0.5651597194614189;0.5728208715916296;7.400047131651798;38.26822196421712;4.255612709818223;0.001280802949978559;0.5078732437472537;[, CDH1, TNR, CLDN7, TGFB1, IFNA2, ARHGAP6, EPCAM, SIPA1]
GO:1900126;negative regulation of hyaluronan biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;591.2837729800367;8.67846133901236;0.019789735760794357;0.8400575416471059;[TGFB1]
GO:0006754;ATP biosynthetic process;11.0;0.7043150770688792;0.7845864908641018;9.424925297250882;8670.873920960137;5.433268205826786;0.29020634685463875;0.7102865410484548;[TGFB1]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[TGFB1, ATP2A3]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, AES]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[TGFB1]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, IFNA14, IFNA16, IFNA10, CORO1A, IFNA21, TGFB1, HIST1H2BK]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[TGFB1, GNAI2]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, ST14, MMP12, APEH, ADAMTS20, SKP2, RANBP1, TGFB1]
GO:0030032;lamellipodium assembly;6.0;0.8933024483968273;0.7697715367885581;9.533214072687796;78.21732158183345;6.311337724880743;0.002617863362324714;0.6458824173477649;[NUP85, SH2B1]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[STXBP2, ZYX]
GO:0030279;negative regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.83246312675316;5.500407508664414;0.0014000948940798496;0.571532107649126;[TGFB1]
GO:0036258;multivesicular body assembly;7.0;1.0;0.8509193652572005;9.628524252492122;62.72328125453724;6.375876246018314;0.0020992917763011008;0.6769819729871445;[HGS]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[TLN1, CORO1A, RHOG, FLNA, KRT19, ZYX]
GO:0060761;negative regulation of response to cytokine stimulus;5.0;0.6954798709641801;0.6379809473430103;8.438940185618286;40.831621184480156;5.734022359845919;0.001366597614971242;0.5834791820027497;[NR1H2, AES, MMP12]
GO:0007093;mitotic cell cycle checkpoint;7.0;0.7140352122741334;0.7079369713942671;9.0094850440859;132.2042645947957;5.142344639450834;0.0044247577598742595;0.6138991092621975;[KNTC1, TGFB1, CDC6, WEE1]
GO:0060762;regulation of branching involved in mammary gland duct morphogenesis;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;93.99544391330774;8.16763571524637;0.0031459429173709623;0.7408135829017477;[TGFB1]
GO:0014067;negative regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;7.292166977892469;0.00799223380789131;0.747921758369865;[TSC2]
GO:0016925;protein sumoylation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;311.84626772129184;6.250713103064308;0.010437213937211602;0.7159023839588838;[CBX4]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, AKT1, MMP12, AP2M1, ACAP1, ITGB6, POLA2, NUP155, NASP, NUP62, NUP133, NUP54, NUP35, RAN, NUP85, NUP88, CCDC22, STXBP2, XPO1, RANBP1, NUPL2, TSC2, HGS, TGFB1]
GO:1903800;positive regulation of production of miRNAs involved in gene silencing by miRNA;10.0;0.8933024483968273;0.861892236059334;9.566003895510788;702.6387462348895;7.697632086000634;0.023516686502664728;0.8088982747154926;[TGFB1]
GO:0085029;extracellular matrix assembly;5.0;0.7980440201809971;0.6892630219514189;9.176539128749065;38.15502461274271;6.7325511899570465;0.0012770143364957127;0.6345439928109722;[TGFB1]
GO:0051126;negative regulation of actin nucleation;12.0;0.9326813400603323;0.9144609826203107;9.59573442966913;318.2257087533811;7.697632086000634;0.010650728087431447;0.8417775754447168;[CORO1A]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[AKT1, CLDN3, TGFB1]
GO:0007406;negative regulation of neuroblast proliferation;8.0;0.8933024483968273;0.8216512241984136;9.5544162803384;502.0817198454759;8.390779266560578;0.016804223319016428;0.8041048419030481;[TGFB1]
GO:0032967;positive regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;105.22247330055487;6.558197802812269;0.003521701487291661;0.6585068532133508;[TGFB1]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[PPP2R1A, TNR, TGFB1, SIPA1]
GO:0048642;negative regulation of skeletal muscle tissue development;8.0;0.7866048967936545;0.7683024483968273;9.310070521373587;215.71554513694034;7.212124270218933;0.007219805164346847;0.7438283705770736;[TGFB1]
GO:0010936;negative regulation of macrophage cytokine production;8.0;1.0;0.875;9.628524252492122;311.05347994333346;8.16763571524637;0.010410680043746014;0.7926932703116032;[TGFB1]
GO:0050714;positive regulation of protein secretion;8.0;0.6467165523344657;0.6983582761672329;8.730582659286164;381.48337166918856;4.304802954008995;0.01276790513702299;0.5951478232618299;[TGFB1, MMP12, NR1H2]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, SFN, ARHGAP6, E2F7, SH2B1, SPTAN1, PCNA, GNAI2, EPS8L1, STMN1, CIT, FGF5, LHCGR, DGKZ, NRBP1, MELK, CNOT3, PPP2R1A, PRL, MAP4K1, RHOG, SIPA1, TSC2, TGFB1]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, AKT1, IFNA14, IFNA16, IFNA10, IFNA21, TGFB1]
GO:0016239;positive regulation of macroautophagy;8.0;0.7671156992804218;0.7585578496402109;9.242861771680136;266.06548500403863;5.666199763507158;0.008904972339694651;0.6647697194109919;[TSC2]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[CDH1, TGFB1, JUP]
GO:0060751;branch elongation involved in mammary gland duct branching;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;21.218694376440094;9.777073627680469;7.101706051943016E-4;0.8231203125901445;[TGFB1]
GO:1905313;transforming growth factor beta receptor signaling pathway involved in heart development;9.0;0.9326813400603323;0.8625812952104552;9.541512875502493;60.43149861880159;9.777073627680469;0.0020225878739534935;0.896240625180289;[TGFB1]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[, AKT1, SFN, JUP, EZH2, ARHGAP6, MMP12, FLNA, BIK, ADAMTS20, SH2B1, GNAI2, NUP62, SEH1L, FGF5, CDH3, CCDC22, PPP2R1A, SKP2, POR, IFNA2, PRL, MAP4K1, TGFB1]
GO:0006334;nucleosome assembly;7.0;0.8653626801206646;0.7836007053175329;9.474373572664863;104.51542930890014;4.99795013456894;0.0034980373611892576;0.6065147675675062;[BRD2, MCM2, HIST1H2BK, H1FX, NASP]
GO:0090190;positive regulation of branching involved in ureteric bud morphogenesis;8.0;1.0;0.875;9.628524252492122;298.04283299406984;6.832634648514029;0.009975225399176214;0.7244212536750128;[TGFB1]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[TGFB1]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[, TGFB1, EZH2, MAP4K1]
GO:0043405;regulation of MAP kinase activity;11.0;0.6634067003016617;0.7641323024804931;9.028903129943;322.70119747860093;3.951073520300019;0.0108005186673862;0.6344870359015141;[, PPP2R1A, EZH2, MAP4K1, HGS, TGFB1, NUP62]
GO:0031065;positive regulation of histone deacetylation;10.0;0.8933024483968273;0.861892236059334;9.571365838652174;1219.9035963218012;6.8867018697843045;0.04082907552693193;0.7674272657460779;[TGFB1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPINT1, SFN, CDC6, PRL, TSC2, HGS, TGFB1, HMGA1, NUP62, E2F7]
GO:0002062;chondrocyte differentiation;4.0;0.8933024483968273;0.6966512241984136;9.446202695698167;21.066225782797595;6.039404009397101;7.050676185779127E-4;0.5588554019015759;[TGFB1]
GO:1901525;negative regulation of mitophagy;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;765.9069832582293;7.9853141584524145;0.0256342174581193;0.8046099625986299;[TSC2]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[UBE2M]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[CORO1A]
GO:0006415;translational termination;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;39.9935520007603;5.223196736079928;0.001338548193605436;0.5902348365767605;[APEH]
GO:0071677;positive regulation of mononuclear cell migration;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;295.2864367703214;6.686031174322154;0.009882971298162901;0.7381645703673706;[TGFB1]
GO:0032700;negative regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.25422870398782;7.292166977892469;0.002184000309729388;0.6960420709600095;[TGFB1]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[IFNA2, TGFB1]
GO:0016236;macroautophagy;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;39.83166466328102;5.244474134527214;0.0013331299701091492;0.5584436629936305;[HGS]
GO:0043537;negative regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;356.3539069568923;6.311337724880743;0.01192684456815238;0.7380031166185408;[TGFB1, JUP]
GO:0031293;membrane protein intracellular domain proteolysis;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;50.748517158788495;6.8867018697843045;0.0016985071986044009;0.7031056191423581;[TGFB1]
GO:0051280;negative regulation of release of sequestered calcium ion into cytosol;10.0;0.8933024483968273;0.861892236059334;9.566003895510788;673.651588659943;7.212124270218933;0.02254651242537939;0.7840693824379941;[TGFB1]
GO:0043536;positive regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;355.43002650478036;5.8067817141283475;0.011895923120858621;0.7122000987644093;[AKT1, TGFB1]
GO:0061502;early endosome to recycling endosome transport;6.0;1.0;0.8231203125901445;9.628524252492122;50.18376484494501;9.083926447120524;0.001679605446904144;0.7876727335416686;[CORO1A]
GO:0009817;defense response to fungus, incompatible interaction;7.0;1.0;0.8509193652572005;9.628524252492122;143.15190279508232;9.777073627680469;0.004791165358203135;0.8509193652572005;[TGFB1]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CORO1A, TGFB1]
GO:0001657;ureteric bud development;8.0;1.0;0.875;9.628524252492122;36.921511297847346;6.139487467954083;0.0012357297559360753;0.6889736746265369;[TGFB1, EPCAM]
GO:0051152;positive regulation of smooth muscle cell differentiation;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;145.28799013580416;7.292166977892469;0.004862658279143298;0.7238411236270654;[TGFB1]
GO:0010800;positive regulation of peptidyl-threonine phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;778.6672313762616;6.375876246018314;0.026061291479152104;0.7413036195908642;[TGFB1]
GO:0071549;cellular response to dexamethasone stimulus;9.0;1.0;0.896240625180289;9.628524252492122;704.2721689024621;6.343086423195323;0.023571355689363423;0.7206263598461826;[TGFB1]
GO:0030512;negative regulation of transforming growth factor beta receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.537552474286395;374.7458266990886;5.54296712308321;0.012542405570270547;0.6584675964488075;[TGFB1]
GO:0032930;positive regulation of superoxide anion generation;8.0;1.0;0.875;9.628524252492122;144.57516735605006;7.004484905440688;0.00483880074220378;0.7332096838060964;[TGFB1, GNAI2]
GO:0042176;regulation of protein catabolic process;6.0;0.5945822691631375;0.6204114471717133;8.214830917184116;56.791667214012804;3.8826707934156186;0.001900765992470805;0.5216802775280761;[AKT1, XPO1, FLNA, HGS, OSBPL7, CCDC22]
GO:0042059;negative regulation of epidermal growth factor receptor signaling pathway;8.0;0.8436909121759173;0.7968454560879586;9.417215158824915;234.05310184950287;6.113511981550823;0.00783354668478672;0.6876452870438905;[NUP62, HGS]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[STMN1, AKT1, AES]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, CORO1A]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[TGFB1]
GO:2000679;positive regulation of transcription regulatory region DNA binding;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;47.96814533750694;6.641579411751319;0.0016054506559182917;0.6627709925721352;[TGFB1]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CDH3, AP2M1, TLE4, AES]
GO:0030100;regulation of endocytosis;6.0;0.5902001590945054;0.6182203921373972;8.152617732682543;44.90533409728707;4.321752512322768;0.0015029411200592913;0.5441349370523758;[TSC2, TGFB1, NR1H2]
GO:0060395;SMAD protein signal transduction;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;5.734022359845919;7.75488093814194E-4;0.5834791820027497;[TGFB1]
GO:0046426;negative regulation of JAK-STAT cascade;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;286.97803335492995;5.845247994956144;0.009604896512927369;0.6951668794741764;[HGS, PPP2R1A]
GO:0038180;nerve growth factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;27.195621953761602;7.292166977892469;9.102129923216596E-4;0.7238411236270654;[CORO1A]
GO:0048298;positive regulation of isotype switching to IgA isotypes;11.0;1.0;0.9324289523296623;9.628524252492122;1407.9016349495496;8.16763571524637;0.04712120069255247;0.8501222226412654;[TGFB1]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[SKP2, SEH1L, AES, SIPA1]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TGFB1, KRT19]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[AKT1, JUP, MMP12, ATAD2, E2F7, CCNH, HMGA1, NUP62, RAN, EHF, NUP85, EPCAM, NR1H2, GTF2H1, CDH3, CDH1, RFC1, IFNA2, PRL, RHOG, ARID4A, HGS, TGFB1, MEIS2]
GO:0010742;macrophage derived foam cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;7.8311634786251565;7.282666309192915E-4;0.6907270763441554;[TGFB1]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[AKT1, TGFB1]
GO:0050921;positive regulation of chemotaxis;6.0;0.6417349323569144;0.6439877787686017;8.362857879160845;97.3409382187974;4.886724499458715;0.003257913601026301;0.5730276307483924;[TGFB1]
GO:0010862;positive regulation of pathway-restricted SMAD protein phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1012.5567145242198;5.905872616772578;0.033889361993245395;0.7172676121338334;[TGFB1]
GO:0030214;hyaluronan catabolic process;8.0;1.0;0.875;9.628524252492122;501.2795327383162;6.8867018697843045;0.01677737483846132;0.7271862538851576;[TGFB1]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[AKT1, GNAI2, FLNA, CORO1A, TGFB1, LAMC2]
GO:0061035;regulation of cartilage development;5.0;0.7043150770688792;0.6423985503953599;8.781226392104918;27.37613670804801;5.6339389012889365;9.162546586948941E-4;0.5783609092777888;[TGFB1, POR]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[TGFB1]
GO:0001570;vasculogenesis;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;5.6339389012889365;7.050676185779127E-4;0.5381198974168686;[TGFB1]
GO:0042631;cellular response to water deprivation;6.0;0.9326813400603323;0.7894609826203107;9.587702257971866;306.78131104411256;8.67846133901236;0.01026769439539148;0.7669372290569613;[SIPA1]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[PPP2R1A, AKT1, TSC2, SFN, NUP62]
GO:0060744;mammary gland branching involved in thelarche;8.0;1.0;0.875;9.628524252492122;74.22212479985593;8.16763571524637;0.002484147721475594;0.7926932703116032;[TGFB1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EZH2, AES, MMP12, NR1H2, TLE4, RFC1, E2F7, XPO1, TGFB1, CBX4, MEIS2]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[TGFB1, EZH2]
GO:0045591;positive regulation of regulatory T cell differentiation;10.0;0.8933024483968273;0.861892236059334;9.60254876608886;997.8066164740876;7.292166977892469;0.03339568948573388;0.7881627702307852;[TGFB1]
GO:0031536;positive regulation of exit from mitosis;9.0;1.0;0.896240625180289;9.628524252492122;562.0425168150831;8.16763571524637;0.018811057232375368;0.8139338954918922;[TGFB1]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[PCNA, TGFB1, EZH2]
GO:0010716;negative regulation of extracellular matrix disassembly;7.0;1.0;0.8509193652572005;9.628524252492122;86.13995449886744;8.390779266560578;0.002883026756151129;0.7800242071602487;[TGFB1]
GO:0032740;positive regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[TGFB1]
GO:0035338;long-chain fatty-acyl-CoA biosynthetic process;8.0;1.0;0.875;9.628524252492122;500.3176215265477;6.8867018697843045;0.016745180535867314;0.7271862538851576;[TECR]
GO:2000210;positive regulation of anoikis;8.0;1.0;0.875;9.628524252492122;103.81651994310933;7.8311634786251565;0.0034746454936938316;0.7754860644832351;[AES]
GO:0070306;lens fiber cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[TGFB1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[EZH2, FLNA, ATAD2, E2F7, CCNH, HMGA1, NUP62, EHF, HOXA9, ZNF367, BRD2, AES, GTF2H1, TLE4, CNOT3, RFC1, ARID4A, CBX4, MEIS2]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[PRL, TGFB1, CLDN4]
GO:0045116;protein neddylation;9.0;1.0;0.896240625180289;9.628524252492122;153.79381005389072;7.212124270218933;0.005147340417060716;0.7650689957573628;[UBE2M]
GO:0042761;very long-chain fatty acid biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;456.7578576193329;7.212124270218933;0.01528727443913519;0.7650689957573628;[TECR]
GO:1903911;positive regulation of receptor clustering;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;110.66472907477197;8.16763571524637;0.0037038488903424972;0.7926932703116032;[TGFB1]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[AKT1, JUP, EZH2, MMP12, ATAD2, MAZ, E2F7, CCNH, NR3C2, HMGA1, EHF, HOXA9, ZNF367, BRD2, AES, EPCAM, NR1H2, GTF2H1, TLE4, RFC1, PRL, XPO1, ARID4A, TGFB1, CBX4, MEIS2]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[TGFB1]
GO:0048873;homeostasis of number of cells within a tissue;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;26.75021374699733;6.444869117505266;8.953055804826206E-4;0.6527112189764278;[CORO1A]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[AKT1, CLDN7, SFN, UNG, FLNA, CORO1A, ADAMTS20, POR, GNAI2, CBX4, NUP62]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[AKT1, SFN, AES, BIK, MELK, PPP2R1A, TGFB1, UBE2M]
GO:0006904;vesicle docking involved in exocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;32.65265176272962;6.039404009397101;0.0010928548690198408;0.6319757144917204;[STXBP2]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[CORO1A]
